NCT02779413 - A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea | Biotech Hunter

Enrollment

3,303

Participants

Timeline

Start Date

June 2, 2016

Primary Completion Date

June 24, 2019

Study Completion Date

June 24, 2019

Conditions

Diabetes

Interventions

DRUG

insulin degludec

Patients will be treated with commercially available Tresiba® FlexTouch® according to routine clinical practice at the discretion of the treating physician.

Trial Locations (44)

10475

Novo Nordisk Investigational Site, Gyeonggi-do

14647

Novo Nordisk Investigational Site, Bucheon-si

14754

Novo Nordisk Investigational Site, Gyeonggi-do

16247

Novo Nordisk Investigational Site, Suwon-si, Gyeonggi-do

16499

Novo Nordisk Investigational Site, Suwon

21431

Novo Nordisk Investigational Site, Incheon

22332

Novo Nordisk Investigational Site, Incheon

24253

Novo Nordisk Investigational Site, Gangwon-do

25440

Novo Nordisk Investigational Site, Gangwon-do

26426

Novo Nordisk Investigational Site, Gangwon-do

39295

Novo Nordisk Investigational Site, Gyeongsangbuk-do

39371

Novo Nordisk Investigational Site, Gyeongsangbuk-do

41199

Novo Nordisk Investigational Site, Daegu

44455

Novo Nordisk Investigational Site, Ulsan

47227

Novo Nordisk Investigational Site, Busan

47392

Novo Nordisk Investigational Site, Busan

49241

Novo Nordisk Investigational Site, Busan

49267

Novo Nordisk Investigational Site, Busan

54987

Novo Nordisk Investigational Site, Jeonju

Unknown

Novo Nordisk Investigational Site, Busan

Novo Nordisk Investigational Site, Chungcheongnam-do

Novo Nordisk Investigational Site, Daegu

Novo Nordisk Investigational Site, Gyeonggi-do

Novo Nordisk Investigational Site, Gyeongsangnam-do

Novo Nordisk Investigational Site, Seoul

302-718

Novo Nordisk Investigational Site, Daejeon

361-711

Novo Nordisk Investigational Site, Daejeon

405-220

Novo Nordisk Investigational Site, Incheon

431-796

Novo Nordisk Investigational Site, Pyungchon-Dong 896, Dongan-Gu

463-707

Novo Nordisk Investigational Site, Seongnam-si

03722

Novo Nordisk Investigational Site, Seoul

04551

Novo Nordisk Investigational Site, Seoul

04564

Novo Nordisk Investigational Site, Seoul

05278

Novo Nordisk Investigational Site, Seoul

06273

Novo Nordisk Investigational Site, Seoul

06351

Novo Nordisk Investigational Site, Seoul

06591

Novo Nordisk Investigational Site, Seoul

07441

Novo Nordisk Investigational Site, Seoul

138-736

Novo Nordisk Investigational Site, Seoul

139-707

Novo Nordisk Investigational Site, Seoul

139-827

Novo Nordisk Investigational Site, Seoul

150-713

Novo Nordisk Investigational Site, Seoul

682-060

Novo Nordisk Investigational Site, Ulsan

220-701

Novo Nordisk Investigational Site, Wŏnju